(Q37787760)

23 August 2017

1 reference

title

Simvastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolaemia (English)

1 reference

23 August 2017

0 references

1 reference

Todd PA

1

1 reference

PubMed ID

2083515

23 August 2017

Goa KL

series ordinal

2

1 reference

23 August 2017

1 October 1990

1 reference

23 August 2017

1 reference

23 August 2017

40

1 reference

23 August 2017

583-607

1 reference

23 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199040040-00007

23 August 2017

0 references

cites work

[Swiss simvastatin multicenter study: 1. Efficacy of 10 mg simvastatin daily in patients with primary hypercholesterolemia]

1 reference

12 December 2020

Effects of simvastatin and fenofibrate on serum lipoproteins and apolipoproteins in primary hypercholesterolaemia

1 reference

12 December 2020

The clinical efficacy and safety of lovastatin and MK-733--an overview

1 reference

12 December 2020

ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium

1 reference

12 December 2020

Cholesterol synthesis inhibitors in hyperlipidaemia

1 reference

12 December 2020

Simvastatin, a competitive inhibitor of HMG-CoA reductase, lowers cholesterol saturation index of gallbladder bile

1 reference

12 December 2020

Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic

1 reference

12 December 2020

Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I

1 reference

12 December 2020

Fat transport in lipoproteins--an integrated approach to mechanisms and disorders

1 reference

12 December 2020

Colestipol plus fenofibrate versus synvinolin in familial hypercholesterolaemia

1 reference

12 December 2020

Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivo

1 reference

12 December 2020

3-Hydroxy-3-methylglutaryl--coenzyme A reductase inhibitors in the treatment of hypercholesterolemia

1 reference

12 December 2020

Synvinolin in hypercholesterolaemia

1 reference

12 December 2020

Clinical experience with simvastatin compared with cholestyramine

1 reference

12 December 2020

Comparative effects of simvastatin (MK-733) and pravastatin (CS-514) on hypercholesterolemia induced by cholesterol feeding in rabbits

1 reference

12 December 2020

Effect of simvastatin on plasma lipids, apolipoproteins and lipoprotein particles in patients with primary hypercholesterolaemia.

1 reference

12 December 2020

Normal cholesterol levels with lovastatin (mevinolin) therapy in a child with homozygous familial hypercholesterolemia following liver transplantation

1 reference

12 December 2020

Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease

1 reference

12 December 2020

Comparison of simvastatin and cholestyramine in the treatment of primary hypercholesterolaemia

1 reference

12 December 2020

Effects of MK-733 on plasma lipid and lipoprotein levels in subjects with hypercholesterolaemia

1 reference

12 December 2020

Comparison between low-dose simvastatin and cholestyramine in moderately severe hypercholesterolemia.

1 reference

12 December 2020

Mechanism of action and biological profile of HMG CoA reductase inhibitors. A new therapeutic alternative

1 reference

12 December 2020

The effects of simvastatin on serum lipoproteins in severe hypercholesterolaemia

1 reference

12 December 2020

Sorting signals and cellular membranes

1 reference

12 December 2020

Comparison between simvastatin and bezafibrate in effect on plasma lipoproteins and apolipoproteins in primary hypercholesterolaemia

1 reference

12 December 2020

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

1 reference

12 December 2020

The mechanism of action of lipid-lowering drugs

1 reference

12 December 2020

Therapeutic control of hyperlipidemia in the prevention of coronary atherosclerosis: a review of results from recent clinical trials

1 reference

12 December 2020

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent

1 reference

12 December 2020

Effects of MK-733, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, on absorption and excretion of [3H]cholesterol in rabbits

1 reference

12 December 2020

Effects of simvastatin on plasma lipid, lipoprotein and apolipoprotein concentrations in hypercholesterolaemia

1 reference

12 December 2020

EFFECTS OF SIMVASTATIN AND CHOLESTYRAMINE ON LIPOPROTEIN PROFILE IN HYPERLIPIDAEMIA OF NEPHROTIC SYNDROME

1 reference

12 December 2020

Simvastatin and bezafibrate: effects on serum lipoproteins and lecithin: cholesterol acyltransferase activity in familial hypercholesterolaemia

1 reference

12 December 2020

Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth

1 reference

12 December 2020

Adrenocortical function in patients on simvastatin

1 reference

12 December 2020

Monacolin K, a new hypocholesterolemic agent produced by a Monascus species.

1 reference

12 December 2020

Simvastatin (MK 733): an effective treatment for hypercholesterolemia

1 reference

12 December 2020

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

1 reference

12 December 2020

The diagnosis and management of hyperlipidemia

1 reference

12 December 2020

Treatment of dyslipidemia in non-insulin-dependent diabetes mellitus with lovastatin

1 reference

12 December 2020

Lovastatin. A preliminary review of its pharmacodynamic properties and therapeutic use in hyperlipidaemia

1 reference

12 December 2020

Cortisol secretion in patients on simvastatin

1 reference

12 December 2020

Effects of simvastatin and probucol in hypercholesterolemia (Simvastatin Multicenter Study Group II)

1 reference

12 December 2020

Preventive effect of MK-733 (simvastatin), an inhibitor of HMG-CoA reductase, on hypercholesterolemia and atherosclerosis induced by cholesterol feeding in rabbits

1 reference

12 December 2020

Simvastatin and cholestyramine in the long-term treatment of hypercholesterolaemia

1 reference

12 December 2020

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. Side chain ester derivatives of mevinolin

1 reference

12 December 2020

Preclinical evaluation of lovastatin

1 reference

12 December 2020

An overview of lipid-lowering drugs

1 reference

12 December 2020

On the etiology of subcapsular lenticular opacities produced in dogs receiving HMG-CoA reductase inhibitors

1 reference

12 December 2020

Efficacy and safety of simvastatin (alone or in association with cholestyramine). A 1-year study in 66 patients with type II hyperlipoproteinaemia

1 reference

12 December 2020

Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia

1 reference

12 December 2020

Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]

1 reference

12 December 2020

Effects of synvinolin (MK-733) on plasma lipids in familial hypercholesterolaemia

1 reference

12 December 2020

[Effects of simvastatin on plasma lipids, lipoproteins and apoproteins (A1 and B). 24 cases of major primary hypercholesterolemia]

1 reference

12 December 2020

The effects of simvastatin on plasma lipoproteins and cholesterol homeostasis in patients with heterozygous familial hypercholesterolaemia

1 reference

12 December 2020

The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis

1 reference

12 December 2020

Simvastatin (MK-733): a potent cholesterol synthesis inhibitor in heterozygous familial hypercholesterolaemia

1 reference

12 December 2020

Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolaemia

1 reference

12 December 2020

Comparison of low-dose simvastatin and gemfibrozil in the treatment of elevated plasma cholesterol. A multicenter study. The Simvastatin Study Group

1 reference

12 December 2020

Simvastatin (MK 733) in heterozygous familial hypercholesterolemia: a two-year trial

1 reference

12 December 2020

Structure elucidation of the bioactive metabolites of ML-236B (mevastatin) isolated from dog urine

1 reference

12 December 2020

Animal safety and toxicology of simvastatin and related hydroxy-methylglutaryl-coenzyme A reductase inhibitors

1 reference

12 December 2020

Type IIa dyslipoproteinemia. Effects of simvastatin and bezafibrate on atherogenic and non-atherogenic lipoprotein particles

1 reference

12 December 2020

Transient symptomatic hypotension in patients on simvastatin

1 reference

12 December 2020

CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species

1 reference

12 December 2020

Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog

1 reference

12 December 2020

Monacolin K, a new hypocholesterolemic agent produced by a Monascus species.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.32.852

Identifiers

DOI

10.2165/00003495-199040040-00007

1 reference

PubMed ID

2083515

Dimensions Publication ID

23 August 2017

0 references

1 reference

PubMed ID

2083515